| | 
Part, Chapter, Paragraph
1 I, 2. 10. 4| errors (from 3.10% to 0.84%)11. Chelsea and Westminster
2 II, 4. 1 | men and from 76.5 years to 84.0 years (7.5 years gap)
3 II, 4. 2 | women the age groups 70-84 even contributed one third
4 II, 5. 2. 2| age-standardized for 35-84 years: the recommended upper
5 II, 5. 2. 2| recommended upper age limit is 84 years given that between
6 II, 5. 2. 2| given that between 75 and 84 years the number of events
7 II, 5. 2. 2| of events doubles. Above 84 years of age it is difficult
8 II, 5. 2. 2| age groups 35-74 and 35-84 years separately were calculated
9 II, 5. 2. 3| mortality rates only for the 35-84 age range, as suggested
10 II, 5. 2. 3| project.~Among people aged 35-84, stroke accounts for 10%
11 II, 5. 2. 3| women aged 35-74 and 35-84 - 3 years average~ ~In men,
12 II, 5. 2. 3| 2.5, in the age range 75-84 years stroke events double
13 II, 5. 2. 3| rates in the age range 35-84 fell by 63% in Central Europe (
14 II, 5. 2. 3| ICD-9 430-38) - Men aged 35-84 years~ ~Similar results
15 II, 5. 2. 3| 430-38) - Women aged 35-84 years~ ~Morbidity~ ~Table
16 II, 5. 4. 3| before the age band of 75-84 years of age.~Prevalence (
17 II, 5. 4. 3| vary from 16% (Ireland) to 84% (Scotland), with a median
18 II, 5. 4. 3| between 12% (Ireland) and 84% (Netherlands). The median
19 II, 5. 5. 2| 65-69, 70-74, 75-79, 80-84, 85-89, 90-94 and 95-99).~ ~
20 II, 5. 5. 2| year age groups from 60 to 84 years and for people over
21 II, 5. 5. 3| native-born individuals (ratio 1.84), and lower in the least
22 II, 5. 5. 3| 91-0.97), 0.88 (95% CI 0.84-0.92), and 0.75 (95% CI
23 II, 5. 5. 3| incidence in persons aged 65 to 84, from the Italian longitudinal
24 II, 5. 5. 3| 100,000 for people aged 65-84 (Baldereschi et al, 2000).
25 II, 5. 6. 2| Osteoporosis Reports 2005; 3: 84-91 (Woolf and Pfleger, 2005)~ ~
26 II, 5. 6. 3| 64 and third at age 65 – 84 after dementia and stroke.~ ~
27 II, 5. 6. 3| prevalence varies between 58% and 84%. Back pain is very common
28 II, 5. 6. 6| countries. Curr Osteoporos Rep 3:84-91~Woolf AD, Zeidler H,
29 II, 5. 7. 7| Soc Nephrol 2006; 17:2275-84.~Hallan SI, Dahl K, Oien
30 II, 5. 11. 3| were the most common sites (84.2% BCC and 74.7% SCC) followed
31 II, 9. 1. 1| Engl J Med 2000;343(6):378-84.~ ~Zeitlin J, Blondel B,
32 II, 9. 3. 1| British Journal of Urology. 84(1): p. 50-56.~ ~Beral V (
33 II, 9. 3. 2| Engl J Med 2000;343(6):378-84.~ ~Zeitlin J, Blondel B,
34 II, 9. 3. 3| research. Sex Transm Infect 77: 84-92.~Gremy I, Beltzer N (
35 II, 9. 4. 3| deaths among older people (65-84 years of age) and over 50%
36 II, 9. 4. 3| 5% in people aged 65 to 84, to 7% in those aged over
37 II, 9. 4. 5| single pathology - the other 84% have multiple illnesses
38 II, 9. 4. 7| Sci Med Sci, (12), p.1277-84.~DECODE study group on behalf
39 II, 9. 5. 3| estimated that there are 84 million people in Europe
40 III, 10. 1. 3| intake. Proc Nutr Soc 57:77-84.~King NA (1999): What processes
41 III, 10. 1. 3| analyses. Drug Alcohol Depend 84(2):167-174.~Kuntsche EN,
42 III, 10. 2. 1| upper age limit from 64 - 84 years. Moreover, population
43 III, 10. 4. 5| contamination in Luxembourg (84 % of all sources), Latvia (
44 III, 10. 6. 1| from 23% (Great Britain) to 84% (France). In 8 of the countries/
45 IV, 11. 6. 4| hypertension, TB, AIDS (84.5% based on historical spend)~
|
|
| |
